-
Genotype data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006201
-
Raw RNA-seq data for clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Dataset
EGAD00001006205
-
Breast Cancer Histology Images
Dataset
EGAD00010001911
-
Elevated somatic mutation burdens in normal human cells due to defective DNA polymerases
Dataset
EGAD00001006212
-
Heterogeneous Genomic Evolution and Immune Microenvironments in Metastatic Lung Cancer
Dataset
EGAD00001006213
-
Whole exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer
Dataset
EGAD00001006217
-
Cancer Alliance Exome
Dataset
EGAD00001006236
-
February 2020 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency as part of the International Human Epigenome Consortium.
Dataset
EGAD00001006220
-
SPECTA Lung cancer RNA FASTQ files
Dataset
EGAD00001006222
-
SPECTA Lung cancer DNA FASTQ files
Dataset
EGAD00001006223
-
Neoplastic pancreatic cysts and associated cancers
Dataset
EGAD00001006229
-
Distribution of ctDNA levels in plasma of early-stage non-small cell lung cancer patients measured using personalised ctDNA analysis
Dataset
EGAD00001006230
-
Cancer Alliance WGS
Dataset
EGAD00001006233
-
Cancer Alliance RNA-Seq PolyA
Dataset
EGAD00001006234
-
Cancer Alliance RNA-Seq total RNA
Dataset
EGAD00001006235
-
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Dataset
EGAD00001006237